Sarcoma, Ewing - 20 Studies Found
Recruiting |
: First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years : Ewing Sarcoma Family of Tumors : 2016-12-06 :
|
Terminated |
: Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients : Ewing's Sarcoma : 2002-05-29 :
|
Completed |
: Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma :
|
Available |
: Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma : Ewing Sarcoma : 2017-01-20 : Drug: Ganitumab The patient will receive ganitumab, 18 mg/kg/dose intravenously every 2 weeks until clin |
Withdrawn |
: Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients : Ewing's Sarcoma : 2012-11-19 : Radiation: External Beam Radiotherapy |
Recruiting |
: Phase I Study of Olaprib and Temozolomide for Ewings Sarcoma : Ewing Sarcoma : 2013-05-08 :
|
Recruiting |
: Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma : Ewing's Sarcoma : 2016-04-04 : Biological: pbi-shRNA™ EWS/FLI1 Type 1 LPX Other Name: pbi-shRNA™ EWS/FLI1 Type 1 Lipoplex |
Completed |
: Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma : Ewing's Sarcoma : 2012-04-18 : Drug: Olaparib 400mg PO BID Continuous Other Name: A |
Recruiting |
: ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide or Irinotecan in Patients With Previously Treated, Incurable Ewing Sarcoma : Ewing Sarcoma : 2014-01-21 :
|
Recruiting |
: Protocol for the Treatment of Metastatic Ewing Sarcoma : Ewing's Sarcoma (ES) : 2016-03-23 :
|